NCT03441256

Brief Summary

Possover pioneered a minimally invasive and fully reversible laparoscopic technique, laparoscopic implantation of neuroprosthesis (LION), for precise placement of an implantable pulse generator and one to four leads for stimulating nerves of the lumbosacral plexus. Unexpectedly, Possover in 2014 made the clinical observation that four patients with complete and incomplete chronic traumatic spinal cord injury regained significant motor and sensory function following the LION procedure for bladder and bowel dysfunction. The primary objective of this randomized clinical trial is to investigate whether the LION procedure and the subsequent neurostimulation in individuals with chronic traumatic thoracolumbar spinal cord injury with spastic paraplegia is associated with increased walking capacity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2018

Completed
23 days until next milestone

First Submitted

Initial submission to the registry

January 24, 2018

Completed
29 days until next milestone

First Posted

Study publicly available on registry

February 22, 2018

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2020

Completed
Last Updated

September 28, 2021

Status Verified

March 1, 2021

Enrollment Period

3 years

First QC Date

January 24, 2018

Last Update Submit

September 22, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Improvement/change in walking capacity

    Walking index for spinal cord injury, second revision (WISCI II)

    Baseline, 3 mo., 6 mo., 9 mo., 12 mo.

Secondary Outcomes (15)

  • Change in lean body mass

    Baseline, 12 mo.

  • Change in distal motor latency of motor nerve conduction studies

    Baseline, 12 mo.

  • Change in peak-peak amplitude of motor nerve conduction studies

    Baseline, 12 mo.

  • Change in muscle microarchitecture

    Baseline, 12 mo.

  • Change in muscle motor unit number

    Baseline, 12 mo.

  • +10 more secondary outcomes

Study Arms (2)

Intervention

EXPERIMENTAL

All participant in the intervention group will undergo the LION procedure and subsequent neurostimulation.

Device: LION procedure

Control

ACTIVE COMPARATOR

All participants in the control group will be issued with a device for neuromuscular electrical stimulation.

Device: NMES

Interventions

Laparoscopic implantation of an impulse generator and four leads for electrical stimulation of femoral and sciatic nerves.

Also known as: Neurostimulation
Intervention
NMESDEVICE

Conventional neuromuscular electrical stimulation via surface electrodes.

Also known as: Neuromuscular electrical stimulation
Control

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Willing and able to give informed consent for participation in the clinical investigation, and to comply with all requirements of the clinical investigation
  • Traumatic SCI with:
  • neurological level below T5 and above L2
  • American Spinal Injury Association Impairment Grade A or B
  • spasticity in one or both lower extremities
  • Injury prior at least 12 months prior to enrollment

You may not qualify if:

  • Female subject who is pregnant/planning pregnancy during the clinical investigation.
  • Previous surgery/procedures interfering with the LION procedure incl. the presence of other implanted medical devices.
  • Any other significant disease or disorder which, in the opinion of the Investigator, may either put the subject at risk because of participation in the clinical investigation, or may influence the result of the clinical investigation, or the subject's ability to participate in the clinical investigation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Helge Kasch

Viborg, Central Jutland, 8800, Denmark

Location

Related Publications (1)

  • Possover M, Abrao HM. Low-frequency antidromic pelvic neuromodulation as a potential enhancer of recovery after spinal cord injury: hypothetical promotion of spinal Renshaw cells and corticovagal plasticity. J Spinal Cord Med. 2025 Sep 15:1-7. doi: 10.1080/10790268.2024.2414146. Online ahead of print.

Related Links

MeSH Terms

Conditions

Spinal Cord Injuries

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and Injuries

Study Officials

  • Helge Kasch, MD

    Spinal Cord Injury Centre of Western Denmark

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 24, 2018

First Posted

February 22, 2018

Study Start

January 1, 2018

Primary Completion

December 31, 2020

Study Completion

December 31, 2020

Last Updated

September 28, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will not share

Individual participant data may be requested by other researchers. Approvals from the Danish Data Protection Agency and individual participants will be required before data may be shared.

Locations